What Can You Expect in 2026?
The 5th Novel Conjugates Summit brings clarity to the fast-moving bioconjugate space, with three days dedicated to spotlighting the most exciting advances in novel targeting formats and payloads so you can return to your team equipped with a breadth of insight into the current approaches being explored.
Join 150+ discovery and R&D leaders to explore the key benefits of each novel approach whilst unpicking the crucial considerations in chemistry and biology when moving from concept to clinic, balancing the most valuable technical insight with a broad, cross-modality perspective.
If you’re ready to move beyond the traditional and into the future of targeted delivery in oncology and beyond, this is where the next wave begins.
Unmissable Event Highlights
Engineering Novel Targeting Formats
Explore how multispecifics, antibody fragments, and peptides are being engineered to enhance tumor penetration, unlock previously inaccessible targets, and enable more selective delivery of therapeutic payloads. Hear fresh perspectives from innovators advancing the next wave of targeting strategies.
Innovating Payload Design to Overcome Resistance
Learn how emerging payload classes such as degraders, oligonucletides and immune stimulants are being harnessed to overcome resistance mechanisms and expand conjugate efficacy beyond traditional cytotoxics.
Investor & Pharma Partnering Panel
Hear directly from pharma search & evaluation teams and leading investors on what drives strategic interest in novel conjugate platforms, and how emerging biotechs can position themselves for collaboration or acquisition.
Designing Smarter Linker & Payload Strategies
Join our deep-dive workshop on how linker chemistry, payload potency and targeting format interact to influence conjugate performance.
Building Collaborative Bridges Across Modalities
Join cross-functional discussions between antibody, peptide and oligonucleotide experts to uncover how lessons learned in each modality can accelerate innovation in new conjugate designs and delivery strategies.
Explore the Full Event Guide
- 20+ companies showcasing the rationale and data behind their approach in novel conjugate development
- 5+ pharma search & evaluation experts discussing partnerships within novel conjugates
- 6+ networking hours for learning from others in the space and forming brand new connections
- 2 deep dive workshops for cross-modality collaboration and optimising the design of novel conjugate drugs
- A poster session for allowing delegates to showcase cutting-edge work to the audience
Attending Companies Include
Explore the Agenda
Discover the latest differentiated approaches in bioconjugate design, from next-generation payloads to novel targeting formats. Gain deep insights through data-rich case studies, interactive workshops, and strategic panel discussions.
Partner With Us
Showcase your capabilities alongside leading CDMOs, technology providers, and biopharma innovators shaping the future of ADCs and next-generation conjugates. Position your brand at the center of industry-defining partnerships.
Join Conjugate Experts
Connect with the scientists, business developers, and external innovation leaders driving the evolution of targeted drug conjugates, and build the collaborations that will shape tomorrow’s precision therapeutics.